Skip to main content

Generation Bio Co. (GBIO)

NASDAQ: GBIO · IEX Real-Time Price · USD
3.50
-0.28 (-7.41%)
May 31, 2023, 4:00 PM EDT - Market closed

Generation Bio Co. Market Cap

Generation Bio Co. has a market cap or net worth of $229.86 million as of June 1, 2023. Its market cap has decreased by -25.56% in one year.

Market Cap
229.86M
Enterprise Value
20.18M
1-Year Change
-25.56%
Ranking
#3594
Category
Micro-Cap
Stock Price
$3.50

Market Cap Chart

Since June 12, 2020, Generation Bio Co.'s market cap has decreased from $1.09B to $229.86M, a decrease of -78.89%. That is a compound annual growth rate of -40.83%.

History

DateMarket Cap% Change
May 30, 2023248.30M
-9.54%
May 26, 2023274.50M
3.70%
May 25, 2023264.70M
-5.60%
May 24, 2023280.40M
0.47%
May 23, 2023279.10M
1.42%
May 22, 2023275.20M
-1.18%
May 19, 2023278.50M
1.68%
May 18, 2023273.90M
-0.47%
May 17, 2023275.20M
-7.71%
May 16, 2023298.20M
-3.18%
May 15, 2023308.00M
3.53%
May 12, 2023297.50M
-1.10%
May 11, 2023300.80M
-7.27%
May 10, 2023324.40M
12.80%
May 9, 2023287.60M
3.23%
May 8, 2023278.60M
-0.21%
May 5, 2023279.20M
0.87%
May 4, 2023276.80M
3.32%
May 3, 2023267.90M
-2.19%
May 2, 2023273.90M
-8.55%
May 1, 2023299.50M
2.01%
Apr 28, 2023293.60M
6.26%
Apr 27, 2023276.30M
0.88%
Apr 26, 2023273.90M
-0.44%
Apr 25, 2023275.10M
-0.22%
View and export this data all the way back to 2020. Start Free Trial.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Edgewise Therapeutics, Inc. 634.69M
Seres Therapeutics, Inc. 604.97M
Phathom Pharmaceuticals, Inc. 512.90M
Xeris Biopharma Holdings, Inc. 362.50M
Zynex, Inc. 344.56M
SOPHiA GENETICS SA 283.03M
LianBio 261.48M
Market Cap Rankings